🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Shandra had the opportunity to attend the Toastmasters D84 Conference alongside fellow club members to support one of their own competing for Best Impromptu Talk. They proudly represented their Distinguished Club status, standing united in their commitment to growth.

Today, on #WorldBrainTumorDay, we recognize the many individuals and families affected by brain tumors and the challenges they face every day. We’re grateful to the medical professionals, researchers, and advocates working to improve care and drive progress in treatment.

We strive to ignite innovation in brain cancer research through collaboration, mentorship, and financial support. We're deeply grateful for dedicated scientists like Cathryn Cadwell, M.D., Ph.D., whose work brings hope and progress to patients and families affected by brain cancer.

The BioCentury Grand Rounds in Chicago was an incredible experience! Hilary Keeley had a great opportunity to speak at the Breakfast Workshop: "Venture Philanthropy: More Important Than Ever for Early Stage Funding." These gatherings are always very meaningful!

An amazing ribbon-cutting for the new Duan Family Building at Mayo Clinic! It will house a comprehensive radiation program, including photon, proton, and carbon ion therapies. It will be the 16th center of its kind in the world, and the only one in the Western Hemisphere.

The Sontag Innovation Fund leverages our brain cancer philanthropy and network to accelerate diagnosis, treatment, prevention, and cures. Learn more: bit.ly/3J1LZP9

This month, we honor the strength of those who have overcome cancer. We recognize and celebrate the courage of every survivor. Our commitment to advancing scientific progress is driven by the survivor community and the vision of a future where survivorship is the expectation.

We’re looking forward to the annual Brain Tumor Leadership Strategic Fly-In on July 7 and 8. Leading brain tumor organizations from across the country will join us to explore opportunities for collaboration on research and initiatives.

We partnered with Critical Path Institute (C-Path) through its TRxA program to award a grant supporting new immunotherapy for fatal brain tumors. Jim Olson, Ph.D., and Andrew Mhyre, Ph.D., received the grant to advance a T cell engager (TCE) targeting PD-L1. bit.ly/3HAkpKs

Congratulations to our Sontag Scientific Advisor, Dr. Susan Chang, for receiving the SNO Excellence in Education Award. This prestigious honor recognizes individuals who have shown outstanding dedication to neuro-oncology education, mentoring, and training.

Since 2003, we've invested over $65M to support visionary scientists in brain cancer research. We're inspired not only by their work, but by the powerful community and collaboration they've built together.

The Sontag Foundation wishes everyone a meaningful and safe Independence Day. Today, we reflect on the strength, freedom, and shared purpose that unite us as a nation. #4thofJuly #TheSontagFoundation #IndependenceDay

The 4th annual Brain Tumor Leadership Strategic Fly-In kicks off tomorrow, and we’re excited to connect with leading brain tumor organizations from across the country. This event is an opportunity to share ideas, strengthen partnerships, and collaborate.

The Sontag Innovation Fund invested in a $52M Series B funding round to advance a randomized Phase 2B clinical trial of Alpheus Medical innovative, non-thermal, tumor-selective ultrasound therapy for newly diagnosed glioblastoma. bit.ly/43SKOw0

We were honored to welcome the nation’s leading brain tumor organizations to Ponte Vedra Beach for our Annual Brain Tumor Strategic Fly-In. We engaged in meaningful collaboration, shared ideas, and connected with some of the most dedicated leaders and advocates in the field.

Today, we highlight the urgent need for continued research and innovative treatments for glioblastoma. Our sister organization, Brain Tumor Network, offers free, personalized navigation services to help patients and families manage diagnosis, treatment, and care. bit.ly/3Bg4oTG

We are proud to support Sanjay Srivatsan (DSA '24), Ph.D., in his research into the natural history of glioblastoma. Advancing research that brings us closer to more precise, effective treatments is central to our mission and the impact we strive to make.

Stay connected with the latest updates, stories, and insights from our community. Subscribe to our newsletter for timely news and valuable content delivered straight to your inbox. 🧠📥 bit.ly/3Fd1j8l #SontagFoundation #CommunityUpdates #BrainCancerResearch

World Brain Day is a global call to recognize the importance of brain health and the urgent need for continued research and innovation. We’re committed to advancing brain cancer research by investing in visionary scientists who are driving bold, transformative breakthroughs.

The Sontag Innovation Fund drives progress in brain cancer research by investing in innovative companies like Alpheus Medical, EnClear Therapies, modifibio, AiM Medical Robotics, Kiyatec, Myosin Therapeutics, MimiVax, Inc, TippingPoint Biosciences, and Telo Therapeutics, Inc.